Authors
Jochen Schmitt, Phyllis Spuls, Maarten Boers, Kim Thomas, Joanne Chalmers, Evelien Roekevisch, Mandy Schram, Richard Allsopp, Valeria Aoki, Christian Apfelbacher, Carla Bruijnzeel‐Koomen, Marjolein Bruin‐Weller, Carolyn Charman, Arnon Cohen, Magdalene Dohil, Carsten Flohr, Masutaka Furue, Uwe Gieler, Lotty Hooft, Rosemary Humphreys, Henrique Akira Ishii, Ichiro Katayama, Willem Kouwenhoven, Sinéad Langan, Sue Lewis‐Jones, Stephanie Merhand, Hiroyuki Murota, Dedee F Murrell, Helen Nankervis, Yukihiro Ohya, Arnold Oranje, Hiromi Otsuka, Carle Paul, Yael Rosenbluth, Hidehisa Saeki, Marie‐Louise Schuttelaar, Jean‐Francois Stalder, Åke Svensson, Roberto Takaoka, Carl‐Fredrik Wahlgren, Stephan Weidinger, Andreas Wollenberg, Hywel Williams
Publication date
2012/9
Journal
Allergy
Volume
67
Issue
9
Pages
1111-1117
Description
The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence‐based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence‐based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long‐term control of …
Total citations
Scholar articles
J Schmitt, P Spuls, M Boers, K Thomas, J Chalmers… - Allergy, 2012